An independent pilot study to identify predictors of response to therapy with ipilimumab in patients with metastatic melanoma.
Phase of Trial: Phase II
Latest Information Update: 24 Sep 2015
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 24 Sep 2015 New trial record